Testosterone Gel
FDA Recall NDC 64380-152
Latest: Class II · Status: Completed · Initiated Mar 05, 2025 · 2 enforcement reports
Active & Historical Enforcement Reports
The FDA has identified 2 recorded enforcement report(s) associated with Testosterone (NDC 64380-152). A significant event, classified as Class II, was initiated on Mar 05, 2025 by Strides Pharma Science Limited. The reported reason for this action was: "Presence of foreign substance: Presence of Benzene."
This specific recall has a current status of COMPLETED, indicating that the FDA considers the recall process finished or the product successfully recovered.
This specific recall has a current status of COMPLETED, indicating that the FDA considers the recall process finished or the product successfully recovered.
Reported Recall Events
Class II Completed
Presence of foreign substance: Presence of Benzene.
Mar 05, 2025
Apr 02, 2025
195,952 Cartons; 30 sachets/Carton.
Recall Profile & Regulatory Data
Event ID
96412
Classification
Class II
Enforcement Status
Completed
Recalling Firm
Strides Pharma, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the U.S
Product Description
Testosterone Gel 1%, 2.5 grams, 30 Unit-dose packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-151-02
Batch or Lot Expiration Information
Lot# : 5501127A, 5501236A, Exp Apr-25; 5501341A, Exp Jun-25; 5501406A, Exp Jul-25; 5501408A, Exp Aug-25; 5501516A, Exp Sep-25; 5501568A, Exp Oct-25; 5501829A, Exp Mar-26; 5502000A, Exp Jul-26; 5502004A, 5502005A, Exp Aug-26; 5502092A, Exp Oct-26; 5502217A, Exp Dec-26; 5502262A, Exp Jan-27
Affected Packages Involved in this Recall
64380-152-01Testosterone
64380-152-02Testosterone
64380-151-01Testosterone
64380-151-02Testosterone
Class II Completed
Presence of foreign substance: Presence of Benzene.
Mar 05, 2025
Apr 02, 2025
244,412 Cartons; 30 sachets /Carton
Recall Profile & Regulatory Data
Event ID
96412
Classification
Class II
Enforcement Status
Completed
Recalling Firm
Strides Pharma, Inc.
Voluntary / Mandated
Voluntary: Firm initiated
Distribution Pattern
Nationwide in the U.S
Product Description
Testosterone Gel 1%, 5 grams, 30 Unit-dose Packets in a carton, Rx only, Distributed by: Strides Pharma Inc., East Brunswick, NJ, NDC 64380-152-02
Batch or Lot Expiration Information
Lot# : 5501103A, Exp Mar-25; 5501237A, 5501238A, Exp Apr-25; 5501278A, Exp May-25; 5501280A, 5501342A, Exp Jun-25; 5501372A, Exp Jul-25; 5501496A, Exp Aug-25; 5501499A, Exp Sep-25; 5501580A, Exp Oct-25; 5501582A, Exp Dec-25; 5501653A, 5501656A, Exp Jan-26; 5501770A, Exp Feb-26; 5501842A, 5501868A, 5501882A, Exp Apr-26; 5501957A, Exp May-26; 5502001A, Exp Jul-26; 5502033A, Exp Aug-26; 5502112A, 5502115A, Exp Oct-26; 5502180A, 5502181A, Exp Nov-26.
Affected Packages Involved in this Recall
64380-152-01Testosterone
64380-152-02Testosterone
64380-151-01Testosterone
64380-151-02Testosterone
About FDA Recall Enforcement Reports
FDA recall data documents classified recall actions associated with a product. Most recalls are limited to specific lots, batches, or package configurations rather than every unit of a drug.
If a recall is listed for an NDC, review the affected lot information and package details carefully. Patients and healthcare professionals should confirm whether a specific product in hand matches the lot or package information before assuming it is affected.